Cardio-Oncology Considerations in Oncologic Treatment Decisions
Anecita P. Fadol, PhD, FNP-BC, FAANP, FAAN
From The University of Texas MD Anderson Cancer Center, Houston, Texas
Presenter’s disclosure of conflicts of interest is found at the end of this article.
J Adv Pract Oncol 2022;13(3):237–242 |
© 2022 Harborside™
At JADPRO Live Virtual 2021, presenter Anecita P. Fadol, PhD, FNP-BC, FAANP, FAAN, emphasized the critical role advanced practitioners play in the identification, monitoring, and management of the cardiac complications of cancer therapy. Dr. Fadol’s presentation discussed identification of the most common cardiotoxicities associated with cancer therapy, clinical considerations related to common oncologic treatments with potential cardiotoxicity that may impact cancer treatment decisions, and the management of common cardiovascular issues in patients with cancer.
For access to the full length article, please sign in